Dr Sin Yong · MBBS (NUS) · MRCS (Edin) · MSc Aesthetic Medicine (London) · MSc Practical Dermatology (Cardiff) · International KOL
Sometimes the right step is dissolving. Sometimes it is waiting. It is rarely more product. An assessment-first consultation for filler that feels heavy, puffy, migrated, lumpy — or simply too much. Hyaluronic acid filler can be dissolved in a targeted way with hyaluronidase; Ellanse, Sculptra and other non-HA fillers cannot be dissolved, and are given honest management options instead.
Answer three questions and send them straight to Dr Sin Yong on WhatsApp — he will tell you whether an ultrasound assessment is worthwhile. No obligation, no hard sell.
Your answers open in your own WhatsApp app — nothing is stored on this page.
If you have already seen one or two clinics about this, you have probably heard the same suggestion: add filler somewhere else to balance it out, or to camouflage it. Sometimes that advice is reasonable. Often it is not what you want. You came in feeling there is too much in your face — and left with a plan to put in more.
This consultation starts from a different position. The filler is the thing being assessed. Adding volume is one option among several, and it is frequently the wrong one for overfilled, pillow-face, heavy or migrated filler. Filler removal, partial dissolving, or simply time are all legitimate outcomes. So is being told that nothing needs to be done. No treatment is decided before the assessment is complete.
Your filler history, as far as you know it — which products, which areas, roughly when. Bring records or receipts from previous clinics if you have them; if you do not, the assessment still proceeds. The face is examined at rest and in animation, and the tissue is palpated for depth, firmness and edges. Ultrasound can be used to map where the product actually sits before any dissolving decision, so treatment is directed at the filler rather than guessed at.
Not everything that feels heavy after filler is filler. Fluid retention, weight change, natural ageing and the way older HA product holds water can all contribute. Part of the assessment is separating what is product from what is you — because dissolving cannot fix what is not filler.
Too much volume overall, or volume in the wrong plane — the puffy, rounded ‘pillow face’ pattern that blunts your natural contours. Selective dissolving lets the excess go down rather than layering more on top.
Filler does not always stay where it was placed. It can spread beyond the treated area or sit more superficially than intended. Migrated hyaluronic acid can be mapped and dissolved in a targeted way.
A hard lump after filler in the first weeks is usually product or swelling. A firm nodule appearing months or years later can be an inflammatory reaction such as a biofilm or granuloma — that needs examination, not massage or guesswork.
A bluish tint under thin skin — most often after tear trough filler — from hyaluronic acid sitting too superficially and scattering light. Because it is HA, targeted dissolving treats the misplaced product and the tint goes with it.
Ellanse is polycaprolactone (PCL); Sculptra is poly-L-lactic acid (PLLA). Hyaluronidase does not dissolve either. Lumps and nodules from these fillers have management options, decided case by case on examination — never a promise to ‘dissolve’ them.
Some older HA fillers hold water and read as puffiness rather than volume — worse in the mornings or after salty food. The assessment separates water-holding product from swelling and from your own tissue.
Hyaluronic acid fillers (Juvederm, Restylane and similar) can be broken down with hyaluronidase. This can be done in a targeted way — treating the migrated or excess portion rather than stripping everything — and conservatively, reassessing between steps rather than over-correcting in one sitting.
Ellanse, Sculptra and other collagen stimulators do not respond to hyaluronidase — a clinic offering to ‘dissolve’ these is describing something that does not work. These products biodegrade on their own timelines, and nodules have management options that depend on what is found on examination. For older permanent fillers, removal is a more involved conversation — and an honest one.
Sometimes waiting is the correct clinical decision, not a brush-off. Recently injected filler can look worse in its first weeks than it will settle to. Dissolving too early can mean treating a picture that was about to change on its own. If time is likely to help, you will be told so, with a timeframe to reassess.
“Hyaluronidase dissolves hyaluronic acid and nothing else. If someone offers to dissolve Ellanse or Sculptra, they are describing something that does not happen.”Dr Sin Yong
Most filler regret is cosmetic — too much product, the wrong place, a look that isn’t you. Occasionally it is more than cosmetic, and timing changes the differential.
Skin turning white over or near the injected area, or developing a dusky, mottled discolouration, can mean filler is affecting the blood supply — vascular occlusion.
Pain that is worsening rather than settling in the hours or days after injection is not a normal settling pattern and should be assessed the same day.
These signs are time-critical. Do not wait for a routine appointment — seek same-day medical assessment, whether here or with the clinic that injected you.
A thorough filler history — products, areas, timing — followed by clinical examination at rest and in animation, with palpation for depth, firmness and edges. If you do not know what was injected, or it was done overseas, the assessment proceeds the same way, without a lecture.
Where useful, ultrasound imaging is used to visualise where the product is sitting and at what depth — separating filler from swelling, water retention and your own tissue before any decision is made.
Targeted dissolving for hyaluronic acid filler; a case-by-case management plan for Ellanse, Sculptra and other non-HA products; or a recommendation to wait, with a timeframe to reassess. If the right advice is to do nothing, you will be told that too.
Dissolving is staged conservatively, reassessing between steps rather than over-correcting in one sitting. If genuine volume loss is unmasked once excess product is gone, any replacement is planned by anatomy — see volume restoration — rather than re-creating the same problem.
Migrated, layered or unknown product is the most common reason corrections go wrong. The assessment maps what was injected, where it now sits and how it is behaving — before anything is added or removed.
| Wait & monitor | Partial dissolution | Full dissolve & restart | Correct then restore | |
|---|---|---|---|---|
| What it means | Some filler settles or degrades on its own | Hyaluronidase only where product misbehaves | Clearing all accessible filler before rebuilding | Dissolution followed by staged, conservative restoration |
| When it fits | Minor, recent, non-progressive issues | Localised migration or lumps | Extensive migration or unknown products | Faces left deflated or lax after clearance |
| The watch-out | Warning signs should never wait — see above | Under-treating a spreading problem | Not all filler types dissolve | Restoration is the plan's second half, not an upsell |
Which route applies is a clinical finding, not a preference — the 60-second self-assessment above is the screen; the consultation is the map.
“Hyaluronidase dissolves hyaluronic acid and nothing else. If someone offers to dissolve Ellanse or Sculptra, they are describing something that does not happen.”
— Dr Sin Yong
Correction work most often involves under eye filler that reads as puffiness — the tear trough and eye bag filler zone — along with migrated lip, nose and chin filler. Each deposit is located first, then treated deliberately.
The physician mapping your filler is the one manufacturers and conferences put in front of other doctors.
Hyaluronidase begins breaking down hyaluronic acid within minutes of placement; the visible result settles over the following days.
How long HA filler can persist in tissue — and migrated, cross-linked product can outlast that considerably.
Hyaluronidase reverses hyaluronic acid fillers only — polycaprolactone (Ellanse) and poly-L-lactic acid (Sculptra) require different management.
Sometimes, yes. Depending on what the ultrasound assessment shows, options can include partial rather than complete dissolving, energy-based lifting to improve the surrounding support, or simply monitoring. Dissolving is a tool, not an obligation — the assessment decides.
Dr Sin Yong takes a history of what was injected and when, examines the face, and where indicated maps the filler with ultrasound to see exactly where product sits and whether it has migrated. You leave with a clear picture of what is there and a plan — whether or not that plan involves dissolving anything.
At home, you often can’t — that is normal. Time since injection, how the area feels to touch, and how it changes through the day all give clues, and the examination is designed to separate the two. If it is swelling, treating it as filler would be the wrong move.
No. Ellanse is polycaprolactone, and hyaluronidase — the dissolving enzyme — only works on hyaluronic acid. Ellanse lumps and nodules have management options, discussed case by case after examination, but dissolving is not one of them — and it is important you are not told otherwise.
No. Sculptra is poly-L-lactic acid (PLLA) and does not respond to hyaluronidase. Nodules from Sculptra and other collagen stimulators are managed differently, depending on what is found on examination — which is exactly why the assessment comes first.
Dissolving removes filler; it does not remove your own tissue. If the filler was masking a real volume change, the face underneath will show it — this is why dissolving is done conservatively, and why the assessment maps what is product and what is you before anything is injected. If genuine volume loss is unmasked, any replacement is planned by anatomy — see volume restoration — rather than re-creating the same problem.
There is usually some swelling from the process itself before the true result is visible. The realistic timeline for your case is discussed at assessment, because it depends on the product, the amount and the area.
It helps, but it is not required. Records from your previous clinic are useful if you can get them. If you cannot, the examination and ultrasound mapping still give enough information to plan from.
You will not be lectured about it. It is common, and the assessment is the same: establish what is there now and what the sensible options are from here.
Timing changes the differential. A lump in the first days or weeks after injection is usually product placement or swelling, and often settles. A firm nodule appearing months or years later can be an inflammatory reaction such as a biofilm or granuloma, and needs examination rather than massage. Any lump that is painful, growing, or comes with skin colour changes should be assessed promptly.
Blanching (skin turning white), dusky or mottled discolouration, and pain that is worsening rather than settling can mean filler is affecting the blood supply — vascular occlusion. This is time-critical: seek medical assessment the same day, whether with the clinic that injected you or another doctor.
Start with a message, not an appointment. Describe the concern in a WhatsApp message first — what was done, roughly when, and what feels wrong now. You will get a straightforward reply about whether an assessment makes sense, before you commit to coming in.
WhatsApp +65 8023 7170This page is general information, not a diagnosis. Signs suggesting vascular compromise — blanching, dusky mottling, worsening pain — need same-day medical assessment.
Leave your name and mobile number and the clinic will contact you directly. No obligation.